Adefovir dipivoxil (ADV) provides significant clinical benefit, reduces meld score and prevents transplantation in chronic hepatitis B patients wait-listed for liver transplantation (OLT) with lamivudine-resistance (LAM-R)
JOURNAL OF HEPATOLOGY(2005)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要